Proposed Information Collection Activity; Comment Request, 5447-5448 [2019-02915]
Download as PDF
5447
Federal Register / Vol. 84, No. 35 / Thursday, February 21, 2019 / Notices
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
DATES: Comments on the collection(s) of proposed collection of information,
information must be received by the
including each proposed extension or
OMB desk officer by March 25, 2019.
reinstatement of an existing collection
ADDRESSES: When commenting on the
of information, before submitting the
proposed information collections,
collection to OMB for approval. To
please reference the document identifier comply with this requirement, CMS is
or OMB control number. To be assured
publishing this notice that summarizes
consideration, comments and
the following proposed collection(s) of
recommendations must be received by
information for public comment:
the OMB desk officer via one of the
1. Type of Information Collection
following transmissions: OMB, Office of
Request: Reinstatement without change
Information and Regulatory Affairs,
of a previously approved collection;
Attention: CMS Desk Officer, Fax
Title of Information Collection:
Number: (202) 395–5806 OR Email:
Medicaid State Plan Base Plan Pages;
OIRA_submission@omb.eop.gov.
Use: State Medicaid agencies complete
To obtain copies of a supporting
the plan pages while we review the
statement and any related forms for the
information to determine if the state has
proposed collection(s) summarized in
met all of the requirements of the
this notice, you may make your request
provisions the states choose to
using one of following:
implement. If the requirements are met,
1. Access CMS’ website address at
website address at https://www.cms.gov/ we will approve the amendments to the
state’s Medicaid plan giving the state
Regulations-and-Guidance/Legislation/
the authority to implement the
PaperworkReductionActof1995/PRAflexibilities. For a state to receive
Listing.html.
1. Email your request, including your
Medicaid Title XIX funding, there must
address, phone number, OMB number,
be an approved Title XIX state plan.
and CMS document identifier, to
Form Number: CMS–179 (OMB control
Paperwork@cms.hhs.gov.
number 0938–0193); Frequency:
2. Call the Reports Clearance Office at Occasionally; Affected Public: State,
(410) 786–1326.
Local, and Tribal Governments; Number
FOR FURTHER INFORMATION CONTACT:
of Respondents: 56; Total Annual
William Parham at (410) 786–4669.
Responses: 1,120; Total Annual Hours:
22,400. (For policy questions regarding
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA) this collection contact Annette Pearson
at 410–786–6958.)
(44 U.S.C. 3501–3520), federal agencies
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Dated: February 15, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2019–02996 Filed 2–20–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[OMB No.: 0970–0379]
Proposed Information Collection
Activity; Comment Request
Title: Project Outcome Assessment
Survey.
Description: The information
collected by the Project Outcome
Assessment Survey is needed for two
main reasons: (1) To collect crucial
information required to report on the
Administration for Native Americans’
(ANA) established Government
Performance and Results Act (GPRA)
measures, and (2) to properly abide by
ANA’s congressionally-mandated
statute (42 United States Code 2991 et
seq.) found within the Native American
Programs Act of 1974, as amended,
which states that ANA will evaluate
projects assisted through ANA grant
dollars ‘‘including evaluations that
describe and measure the impact of
such projects, their effectiveness in
achieving stated goals, their impact on
related programs, and their structure
and mechanisms for delivery of
services.’’ The information collected
with this survey will fulfill ANA’s
statutory requirement and will also
serve as an important planning and
performance tool for ANA.
Respondents: Tribal Governments,
Native American nonprofit
organizations, and Tribal Colleges and
Universities
amozie on DSK3GDR082PROD with NOTICES1
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses
per
respondent
Average
burden hours
per response
Total
burden
hours
ANA Project Outcome Assessment Survey ....................................................
85
1
6
510
Estimated Total Annual Burden
Hours: 510.
In compliance with the requirements
of the Paperwork Reduction Act of 1995
(Pub. L. 104–13, 44 U.S.C. Chap 35), the
Administration for Children and
Families is soliciting public comment
VerDate Sep<11>2014
17:08 Feb 20, 2019
Jkt 247001
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
and Evaluation, 330 C Street SW,
Washington DC 20201. Attn: ACF
Reports Clearance Officer. Email
address: infocollection@acf.hhs.gov. All
requests should be identified by the title
of the information collection.
E:\FR\FM\21FEN1.SGM
21FEN1
5448
Federal Register / Vol. 84, No. 35 / Thursday, February 21, 2019 / Notices
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2019–02915 Filed 2–20–19; 8:45 am]
BILLING CODE 4184–34–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–D–1939]
Use of Investigational Tobacco
Products; Revised Draft Guidance for
Industry and Investigators;
Availability; Agency Information
Collection Activities; Proposed
Collection; Comment Request
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA) is announcing the
availability of a revised draft guidance
for industry and investigators entitled
‘‘Use of Investigational Tobacco
Products.’’ The revised draft guidance
replaces the draft guidance of the same
title announced in the Federal Register
of September 24, 2015 (September 2015
draft guidance). The revised draft
guidance, when finalized, will describe
FDA’s current thinking regarding the
definition of ‘‘investigational tobacco
product’’ and will discuss the kind of
information FDA intends to consider in
making enforcement decisions regarding
the use of investigational tobacco
products until regulations governing the
use of investigational tobacco products
become effective or FDA provides
written notice of its intent to change its
enforcement policy.
DATES: Submit either electronic or
written comments on the draft guidance
by April 22, 2019 to ensure that the
Agency considers your comment on this
amozie on DSK3GDR082PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:08 Feb 20, 2019
Jkt 247001
draft guidance before it begins work on
the final version of the guidance.
Submit electronic or written comments
on the proposed collection of
information by April 22, 2019.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2014–D–1939 for ‘‘Use of Investigational
Tobacco Products; Revised Draft
Guidance for Industry and Investigators;
Availability; Agency Information
Collection Activities; Proposed
Collection; Comment Request.’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of this draft guidance to the
Center for Tobacco Products, Food and
Drug Administration, Document Control
Center, Bldg. 71, Rm. G335, 10903 New
Hampshire Ave., Silver Spring, MD
20993–0002. Send one self-addressed
adhesive label to assist that office in
processing your request or include a fax
number to which the draft guidance
may be sent. See the SUPPLEMENTARY
INFORMATION section for information on
electronic access to the draft guidance.
FOR FURTHER INFORMATION CONTACT:
With regard to the draft guidance:
Laura Rich or Samantha LohCollado,
E:\FR\FM\21FEN1.SGM
21FEN1
Agencies
[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Pages 5447-5448]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02915]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
[OMB No.: 0970-0379]
Proposed Information Collection Activity; Comment Request
Title: Project Outcome Assessment Survey.
Description: The information collected by the Project Outcome
Assessment Survey is needed for two main reasons: (1) To collect
crucial information required to report on the Administration for Native
Americans' (ANA) established Government Performance and Results Act
(GPRA) measures, and (2) to properly abide by ANA's congressionally-
mandated statute (42 United States Code 2991 et seq.) found within the
Native American Programs Act of 1974, as amended, which states that ANA
will evaluate projects assisted through ANA grant dollars ``including
evaluations that describe and measure the impact of such projects,
their effectiveness in achieving stated goals, their impact on related
programs, and their structure and mechanisms for delivery of
services.'' The information collected with this survey will fulfill
ANA's statutory requirement and will also serve as an important
planning and performance tool for ANA.
Respondents: Tribal Governments, Native American nonprofit
organizations, and Tribal Colleges and Universities
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
ANA Project Outcome Assessment Survey....... 85 1 6 510
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 510.
In compliance with the requirements of the Paperwork Reduction Act
of 1995 (Pub. L. 104-13, 44 U.S.C. Chap 35), the Administration for
Children and Families is soliciting public comment on the specific
aspects of the information collection described above. Copies of the
proposed collection of information can be obtained and comments may be
forwarded by writing to the Administration for Children and Families,
Office of Planning, Research and Evaluation, 330 C Street SW,
Washington DC 20201. Attn: ACF Reports Clearance Officer. Email
address: infocollection@acf.hhs.gov. All requests should be identified
by the title of the information collection.
[[Page 5448]]
The Department specifically requests comments on: (a) Whether the
proposed collection of information is necessary for the proper
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2019-02915 Filed 2-20-19; 8:45 am]
BILLING CODE 4184-34-P